- View the NHLBI Biorepository Guide to Building Biospecimen Collections
- View the NHLBI Biorepository video: NHLBI Biospecimen and Data Repository Program: Advancing Medical Research
Search for Study Datasets and/or Biospecimens
Featured News - 6 Items
This funding opportunity is to support meritorious exploratory research relevant to the NHLBI mission using the biospecimen collections that are stored in the NHLBI Biorepository and that are available through BioLINCC. The next application due date is February 15, 2019.
For more information on RFA-HL-17-022 please visit:
The Imaging Core Lab of the National Registry of Genetically Triggered Thoracic Aortic Aneurysms (GenTAC) is now considering applications from researchers who have obtained GenTAC data through BioLINCC and who wish to have additional or novel evaluation of GenTAC images beyond the image readings obtained under the original GenTAC study protocol. The application form, instructions, and contact information for the Imaging Core Lab will be made available for request upon approval and fulfillment of a GenTAC data request through BioLINCC.
The RFA-HL-17-022 funding opportunity now has a FAQ available here: https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/all-funding-opportunity-announcements-1745
AIDS application due dates have been added to the Funding Opportunity Announcement for RFA-HL-17-022 "Maximizing the Scientific Value of the NHLBI Biorepository: Scientific Opportunities for Exploratory Research (R21)". The next application due date is January 7, 2019.
For more information, please visit: https://grants.nih.gov/grants/guide/notice-files/NOT-HL-17-565.html
This funding opportunity is to stimulate the use of existing human datasets for well-focused secondary analyses to investigate novel scientific ideas or new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the NHLBI mission. The next application due date is February 22, 2019.
For more information on PAR-17-004 please visit:
A new open-access paper about BioLINCC metrics and results is now available on PLOS ONE:
Giffen CA, Wagner EL, Adams JT, Hitchcock DM, Welniak LA, Brennan SP, Carroll LE. “Providing researchers with online access to NHLBI biospecimen collections: The results of the first six years of the NHLBI BioLINCC program”.
Data have been updated for the Hispanic Community Health Study / Study of Latinos (HCHS-SOL). The data now include data from the Youth ancillary study.
A new study, Blood and Marrow Transplant Clinical Trials Network (BMT CTN) A Randomized Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etaner...
A new study, Blood and Marrow Clinical Trials Network (BMT CTN) A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids with Mycophenolate Mofetil vs. Cort...